Search

Your search keyword '"Indini A"' showing total 530 results

Search Constraints

Start Over You searched for: Author "Indini A" Remove constraint Author: "Indini A"
530 results on '"Indini A"'

Search Results

1. Current Insights on the Treatment of Anaplastic Lymphoma Kinase-Positive Metastatic Non-Small Cell Lung Cancer: Focus on Brigatinib

2. Efficacy of anti PD-1 therapy in children and adolescent melanoma patients (MELCAYA study)

3. Combined immunotherapy in melanoma patients with brain metastases: A multicenter international study

4. Discontinuation of anti-PD1 in advanced melanoma: an observational retrospective study from the Italian Melanoma Intergroup

6. Cutaneous Melanoma

7. Elective surgery system strengthening: development, measurement, and validation of the surgical preparedness index across 1632 hospitals in 119 countries

8. Single-agent anti-PD-1 or combined with ipilimumab in patients with mucosal melanoma: an international, retrospective, cohort study

9. Evaluation of COVID-19 impact on DELAYing diagnostic-therapeutic pathways of lung cancer patients in Italy (COVID-DELAY study): fewer cases and higher stages from a real-world scenario

12. Cemiplimab in Ultra-Octogenarian Patients with Cutaneous Squamous Cell Carcinoma: The Real-Life Experience of a Tertiary Referral Center

14. Factors predicting morbidity in surgically-staged high-risk endometrial cancer patients

15. Uterine serous carcinoma

16. Better survival of patients with oligo- compared with polymetastatic cancers: a systematic review and meta-analysis of 173 studies [version 4; peer review: 2 approved]

18. Better survival of patients with oligo- compared with polymetastatic cancers: a systematic review and meta-analysis of 173 studies [version 4; peer review: 2 approved]

20. Better survival of patients with oligo- compared with polymetastatic cancers: a systematic review and meta-analysis of 173 studies [version 3; peer review: 1 approved, 1 approved with reservations]

24. Better survival of patients with oligo- compared with polymetastatic cancers: a systematic review and meta-analysis of 173 studies [version 2; peer review: 2 approved with reservations]

26. Better survival of patients with oligo- compared with polymetastatic cancers: a systematic review and meta-analysis of 173 studies [version 1; peer review: 1 approved with reservations]

27. NAD/NAMPT and mTOR Pathways in Melanoma: Drivers of Drug Resistance and Prospective Therapeutic Targets

28. Cemiplimab in Ultra-Octogenarian Patients with Cutaneous Squamous Cell Carcinoma: The Real-Life Experience of a Tertiary Referral Center

30. Factors predicting morbidity in surgically-staged high-risk endometrial cancer patients

32. Penerapan Metode MOORA Dalam Pemilihan Bimbingan Belajar Terbaik

36. Cancer Mechanisms and Emerging Therapies

37. COVID-19 Vaccination in Patients with Classic Kaposi’s Sarcoma

38. Targeting KRAS in Solid Tumors: Current Challenges and Future Opportunities of Novel KRAS Inhibitors

39. Safety of Extended interval Dosing Immune Checkpoint Inhibitors: a multicentre cohort study

40. Safety of extended interval dosing immune checkpoint inhibitors:a multicenter cohort study

42. BYL719 (alpelisib) for the treatment of PIK3CA-mutated, recurrent/advanced cervical cancer

43. Pelatihan Pembuatan Media Pembelajaran Interaktif dengan Power Point di MIS Al Hidayah

47. Uterine serous carcinoma

49. Incidental ameloblastoma diagnosed after treatment for childhood tumor

50. Risk Prediction and New Prophylaxis Strategies for Thromboembolism in Cancer

Catalog

Books, media, physical & digital resources